Benchmark Lowers PT on Harte-Hanks To $9

Symbols: HHS
Share

The Benchmark Company has lowered the price target on Harte-Hanks (NYSE: HHS) from $10 to $9 and maintains its Hold rating.


 
 
< Previous
Goldman Sachs Discusses Hill-Rom Holdings
Next >
Benchmark Downgrades eResearch Technology To Hold, $6.50 PT
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust